In vitro activity of rifabutin against 293 contemporary carbapenem-resistant Acinetobacter baumannii clinical isolates and characterization of rifabutin mode of action and resistance mechanisms

BACKGROUND: Rifabutin, an oral drug approved to treat Mycobacterium avium infections, demonstrated potent activity against Acinetobacter baumannii in nutrient-limited medium enabled by rifabutin cellular uptake through the siderophore receptor FhuE. OBJECTIVES: To determine rifabutin in vitro activi...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:J Antimicrob Chemother
Auteurs principaux: Trebosc, Vincent, Schellhorn, Birgit, Schill, Julian, Lucchini, Valentina, Bühler, Jacqueline, Bourotte, Marilyne, Butcher, Jonathan J, Gitzinger, Marc, Lociuro, Sergio, Kemmer, Christian, Dale, Glenn E
Format: Artigo
Langue:Inglês
Publié: Oxford University Press 2020
Sujets:
Original Research
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7662187/
https://ncbi.nlm.nih.gov/pubmed/32869081
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jac/dkaa370
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires